Martin Babler Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Martin Babler.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Martin Babler. Martin Babler is a Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and a Director in Neoleukin Therapeutics, Inc. ($NLTX) and a Director in ZS Pharma, Inc. ($ZSPH) and an Chief Executive Officer in Principia Biopharma Inc. ($PRNB) and a President, CEO in Principia Biopharma Inc. ($PRNB).

Address: C/O TALIMA THERAPEUTICS, INC. 75 SHOREWAY ROAD SAN CARLOS 94070 CA

Companies in which Martin Babler is an Insider

INFINITY PHARMACEUTICALS, INC.

Trading Symbol: INFI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Babler: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 23 2008
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Neoleukin Therapeutics, Inc.

Trading Symbol: NLTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Babler: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 13 2021
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Principia Biopharma Inc.

Trading Symbol: PRNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Babler: President, CEO, Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Sep 28 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ZS Pharma, Inc.

Trading Symbol: ZSPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Martin Babler: Director
Holdings: 0 shares
Latest Transaction: Dec 21 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Martin Babler

Sentiment: All, INFI, NLTX, PRNB, ZSPH

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2021NLTXNeoleukin Therapeu ...Babler MartinDirectorOption ExerciseA11.4025,000285,00025,000
Sep 28 2020PRNBPrincipia Biopharm ...Babler MartinPresident, CEOOption ExerciseD67.31200,00013,462,0000
Sep 28 2020PRNBPrincipia Biopharm ...Babler MartinPresident, CEOOption ExerciseD35.42155,0005,490,1000
Sep 28 2020PRNBPrincipia Biopharm ...Babler MartinPresident, CEOOption ExerciseD11.35187,1442,125,0010
Sep 28 2020PRNBPrincipia Biopharm ...Babler MartinPresident, CEOOption ExerciseD7.27115,590840,0040
Sep 28 2020PRNBPrincipia Biopharm ...Babler MartinPresident, CEOOption ExerciseD5.0060,546302,4940
Sep 28 2020PRNBPrincipia Biopharm ...Babler MartinPresident, CEOOption ExerciseD4.7283,004392,0780

View all Martin Babler insider transactions.

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

What Is Illegal Insider Trading?

Illegal Insider trading occurs when a trade has been influenced by the possession of "material" and "non-public" information about the security. Because such information is not available to other investors, a person using it is trying to gain an unfair advantage over others. More ...

What Is Legal Insider Trading?

Insider trading is the buying or selling of shares of a company by someone who has access to material, non-public information on the company. Legal insider trading is when company insiders - officers, directors, employees and 10% owners - buy or sell shares in their company in accordance with securities laws and regulations. More ...

Contact us | Follow us on Twitter